Cellectis S.A. (CLLS)
NASDAQ·Healthcare·Biotechnology
$3.96
-1.25%
Mkt Cap $361.10M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.00
Range $4.00 – $8.00
Implied Upside
+51.5%
Consensus $6.00 vs current $3.96
NASDAQ·Healthcare·Biotechnology
$3.96
-1.25%
Mkt Cap $361.10M
No recent rating data.
Price Target (2 analysts)
$6.00
Range $4.00 – $8.00
+51.5%
Consensus $6.00 vs current $3.96